Brevan Howard Capital Management »

Lyell Immunopharma shares owned by Brevan Howard Capital Management

Quarter-by-quarter ownership of Lyell Immunopharma (LYEL) shares owned by Brevan Howard Capital Management from 13F filings

Historical chart of Brevan Howard Capital Management investment in Lyell Immunopharma

Tip: Access up to 7 years of quarterly data

All positions including Lyell Immunopharma held by Brevan Howard Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lyell Immunopharma by Brevan Howard Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $270k 13k 20.06

More positions owned by Brevan Howard Capital Management

Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Ishares Tr Iboxx Inv Cp Etf (LQD)
NVIDIA Corporation (NVDA)
Tesla Motors (TSLA)
Pdd Holdings Sponsored Ads (PDD)
Ishares Tr China Lg-cap Etf (FXI)
Spdr Gold Tr Gold Shs (GLD)
Select Sector Spdr Tr State Street Fin (XLF)
Agnc Invt Corp Com reit (AGNC)
Ishares Msci Brazil Etf (EWZ)
Meta Platforms Cl A (META)
Palantir Technologies Cl A (PLTR)

View all positions for Brevan Howard Capital Management

Top funds holding Lyell Immunopharma

Arch Venture Corp
Vanguard Group
Foresite Capital Management IV
Orland Properties
Vanguard Capital Management
Almitas Capital
Foresite Capital Management V
Millennium Management
Citadel Advisors
venBio Partners
Alphabet
BlackRock
Geode Capital Management
Susquehanna International
Sc China Holding

View all funds holding Lyell Immunopharma